Abstract

Forty-nine children who received peripheral blood stem cell autografts (PBSCT) were observed for the development of transfusion-related disease (TRD), including cytomegalovirus (CMV) disease, alloimmunization, and graft-versus-host disease (GVHD). Cytoreductive regimens did not include total body irradiation. A comprehensive prophylactic strategy including alkylated hyperimmune CMV globulin and filtered, nonirradiated, leukocyte-poor blood products was applied. Two patients showed temporary refractoriness to platelet transfusion, but none suffered from symptomatic CMV infection or GVHD. Thus, under these conditions the incidence of TRD appears to be low in children undergoing PBSCT.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.